Grantham, Mayo, Van Otterloo & Co (GMO)’s Natus Medical Inc NTUS Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-15,800	Closed	-$518K	–	823
2022 Q2	$518K	Hold	15,800	–	–	﹤0.01%	609
2022 Q1	$415K	Buy	+15,800	New	+$386K	﹤0.01%	616
2021 Q1	–	Sell	-11,900	Closed	-$238K	–	973
2020 Q4	$238K	Sell	11,900 -105,500	-90%	-$2.07M	﹤0.01%	770
2020 Q3	$2.01M	Buy	117,400 +6,800	+6%	+$129K	0.01%	409
2020 Q2	$2.41M	Buy	110,600 +86,300	+355%	+$1.98M	0.02%	379
2020 Q1	$562K	Buy	+24,300	New	+$706K	﹤0.01%	580

Other funds holding NTUS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s NTUS Position: Q3 2022 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 15,800 shares — an estimated $518K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NTUS in Q1 2020 and held it in 6 quarters. The position peaked at $2.41M in Q2 2020. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 15,800 Natus Medical Inc shares in Q3 2022, an estimated $518K.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Natus Medical Inc in Q1 2020 and held it in 6 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Natus Medical Inc position peaked at $2.41M in Q2 2020.
1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2022, filed 10 Nov 2022.